AddLife AB Overview
Pro stress-test →AddLife operates through two segments—Labtech and Medtech—providing analytical instruments, equipment, consumables, reagents, medical devices, and related services to hospitals, laboratories, research institutions, and pharmaceutical companies across Europe. Founded in 1906 and based in Stockholm, Sweden, the company serves niche markets in life sciences and medical technology with a decentralized business model built on acquisitions and organic growth.
Strategic Profile
Pro stress-test →AddLife enters 2026 with improved profitability, a strong balance sheet, and increased acquisition activity, while maintaining positive EBITA margin development. The company leverages a European footprint spanning multiple countries to serve publicly funded healthcare, research institutions, and pharmaceutical sectors, positioning itself as a specialized provider in diagnostics, biomedical research, and medical device solutions.
Competitive Landscape
Pro stress-test →AddLife operates within the Nordic life sciences sector, focusing on selected niches in diagnostics, medical technology, and biomedical research. The company competes with larger global diagnostic and medical device suppliers, but differentiates through focused geographic presence (Nordic/Northern Europe), specialized product offerings, and a decentralized subsidiary operating model that attracts entrepreneurial management teams.
Industry Context
AddLife AB operates in Life Sciences & Medical Technology Distribution.
Key facts
Founded: 1906 · Headquarters: Stockholm, Sweden · Market cap: $1.88B